GB Sciences Inc
OTC:GBLX
GB Sciences Inc
OTC:GBLX
Price:
0.0003
USD
Market Closed
Market Cap:
$122.1k
Balance Sheet
Balance Sheet Decomposition
GB Sciences Inc
GB Sciences Inc
Balance Sheet Decomposition is not available for
GB Sciences Inc
GB Sciences Inc
Balance Sheet
GB Sciences Inc
GB Sciences Inc
Currency: USD
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
3
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
7
|
3
|
7
|
4
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
9
|
14
|
24
|
6
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
6
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
+2 600%
|
0
-63%
|
0
-60%
|
0
-75%
|
1
+5 300%
|
1
+169%
|
2
+68%
|
13
+433%
|
24
+85%
|
30
+25%
|
14
-52%
|
11
-25%
|
3
-76%
|
0
-86%
|
0
-70%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
3
|
1
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
4
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Current Liabilities |
1
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
1
|
2
|
7
|
11
|
9
|
4
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
7
|
6
|
4
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-61%
|
0
+64%
|
1
+197%
|
1
+33%
|
1
-11%
|
1
-6%
|
2
+29%
|
3
+102%
|
4
+38%
|
5
+8%
|
11
+141%
|
22
+92%
|
14
-34%
|
12
-15%
|
4
-65%
|
5
+10%
|
5
+14%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
2
|
2
|
2
|
5
|
6
|
6
|
6
|
6
|
14
|
21
|
35
|
58
|
85
|
97
|
104
|
105
|
109
|
110
|
|
| Additional Paid In Capital |
1
|
1
|
2
|
4
|
4
|
4
|
4
|
5
|
11
|
17
|
44
|
71
|
93
|
97
|
102
|
103
|
104
|
105
|
|
| Total Equity |
0
N/A
|
0
-22%
|
0
-64%
|
1
-122%
|
1
-65%
|
1
+7%
|
1
+3%
|
1
+15%
|
2
-66%
|
2
-13%
|
8
N/A
|
13
+53%
|
8
-35%
|
0
N/A
|
1
-1 533%
|
2
-21%
|
4
-148%
|
5
-21%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
+2 600%
|
0
-63%
|
0
-60%
|
0
-75%
|
1
+5 300%
|
1
+169%
|
2
+68%
|
13
+433%
|
24
+85%
|
30
+25%
|
14
-52%
|
11
-25%
|
3
-76%
|
0
-86%
|
0
-70%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
1
|
3
|
1
|
7
|
36
|
47
|
124
|
169
|
241
|
276
|
315
|
325
|
382
|
406
|
|
Switch to:
Switch to:
See Also
Discover More
